首页 > 最新文献

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique最新文献

英文 中文
Genetic Variants Linked to Dyslexia Co-Morbid ADHD: A Case Study of a Pakistani Outpatient. 遗传变异与阅读障碍共病ADHD有关:一个巴基斯坦门诊病人的案例研究。
Shujjah Haider, Tanmoy Mondal, Irum Nawaz, Maleeha Azam, Somiranjan Ghosh

Developmental Dyslexia (DD) and Attention-deficit/hyperactivity disorder (ADHD) are neurodevelopmental disorders that often coexist and share complex genetic underpinnings. Our case study integrates psychological assessments and whole exome sequencing to explore the genetic basis of DD and ADHD co-occurrence in a single proband (a nine-year-old female born to healthy) from a consanguineous Pakistani family. We present a proband with symptoms of impulsivity, inattention, and severe hyperactive behavior, along with speech impairment and moderate learning disabilities. The study identified non-synonymous variations in genes associated with both disorders, such as COMT, ADRA1A, and HTR2A, DNAAF4, DCDC2, KIAA0319, LRRC56, and PHRF1. Network analysis revealed key pathways like S100 Family Signaling, G-Protein Coupled Receptor Signaling, and Dopamine Receptor Signaling shedding light on potential mechanisms underlying the observed phenotypes. The study emphasizes the complexity of these conditions and underscores the need for personalized interventions to address diagnosis challenges.

发展性阅读障碍(DD)和注意力缺陷/多动障碍(ADHD)是经常共存的神经发育障碍,具有复杂的遗传基础。我们的案例研究结合了心理评估和全外显子组测序,以探索来自巴基斯坦一个近亲家庭的单个先证(一名健康出生的9岁女孩)DD和ADHD共同发生的遗传基础。我们提出一个先证者的症状是冲动,注意力不集中,严重的多动行为,以及语言障碍和中度学习障碍。该研究发现了与这两种疾病相关的基因的非同同义词变异,如COMT、ADRA1A和HTR2A、DNAAF4、DCDC2、KIAA0319、LRRC56和PHRF1。网络分析揭示了S100家族信号、g蛋白偶联受体信号和多巴胺受体信号等关键通路,揭示了观察到的表型的潜在机制。该研究强调了这些疾病的复杂性,并强调需要个性化干预措施来应对诊断挑战。
{"title":"Genetic Variants Linked to Dyslexia Co-Morbid ADHD: A Case Study of a Pakistani Outpatient.","authors":"Shujjah Haider, Tanmoy Mondal, Irum Nawaz, Maleeha Azam, Somiranjan Ghosh","doi":"10.53555/rd5d9s46","DOIUrl":"10.53555/rd5d9s46","url":null,"abstract":"<p><p>Developmental Dyslexia (DD) and Attention-deficit/hyperactivity disorder (ADHD) are neurodevelopmental disorders that often coexist and share complex genetic underpinnings. Our case study integrates psychological assessments and whole exome sequencing to explore the genetic basis of DD and ADHD co-occurrence in a single proband (a nine-year-old female born to healthy) from a consanguineous Pakistani family. We present a proband with symptoms of impulsivity, inattention, and severe hyperactive behavior, along with speech impairment and moderate learning disabilities. The study identified non-synonymous variations in genes associated with both disorders, such as <i>COMT</i>, <i>ADRA1A</i>, and <i>HTR2A</i>, <i>DNAAF4</i>, <i>DCDC2</i>, <i>KIAA0319</i>, <i>LRRC56</i>, and <i>PHRF1</i>. Network analysis revealed key pathways like <i>S100 Family Signaling</i>, <i>G-Protein Coupled Receptor Signaling</i>, and <i>Dopamine Receptor Signaling</i> shedding light on potential mechanisms underlying the observed phenotypes. The study emphasizes the complexity of these conditions and underscores the need for personalized interventions to address diagnosis challenges.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"31 9","pages":"2698-2711"},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12415983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of oral candidiasis with oral lichen planus in patients using corticosteroid therapy - Meta-analysis. 使用皮质类固醇治疗的患者口腔念珠菌病与口腔扁平苔藓的关系- meta分析。
Sulaiman S Alqahtani, Faris M Alabeedi

Oral lichen planus (OLP) is a chronic inflammatory disease that commonly affects the skin and mucous membranes. There is a difference of opinion among clinicians about whether OLP has been associated with oral candidiasis. Nonetheless, in OLP patients, the oral candidiasis prevalence rate ranges from 7.7 to 16.6%, as established through biopsy findings, whereas 37-50% of the prevalence rate has been noticed in culture findings. Oral candidiasis has been linked to several local and systemic factors, including salivary gland dysfunction, dental prostheses, topical or inhaled corticosteroids, smoking, and the use of systemic medications. The aim was to highlight the association of Candida in patients diagnosed with OLP, correlate the use of steroid therapy, and enumerate the factors of using steroid therapy as implicated causes for oral candidiasis. A search was made using search engines such as PubMed, Scopus, Cochrane Database of Systematic Reviews, Science Citation Index, NIH Public Access, and Clarivate Analytics (Figure 1). The keywords using the research option for this field were "Oral Candidiasis" AND "Oral Lichen planus" or "Candidiasis" AND "Corticosteroids" or "Topical Corticosteroids" AND Oral Lichen planus or "Inhalation Corticosteroids" AND "Candidiasis" or "Oral Lichen planus" AND "Corticosteroids." The database search was made for the duration of 1991 to -2021 (Table 1). Additional articles were obtained regarding the literature on OLP and oral candidiasis and were considered background material. The incidence of oral candidiasis and associated lichen planus following steroid therapy enlisted by various authors has been addressed. According to the results of this study, there is a positive correlation between the presence of oral candidiasis in the OLP's patients treated with corticosteroids. Finally, this meta-analysis concluded that there is a positive correlation between the presence of Candida species in OLP and steroid medication.

口腔扁平苔藓(OLP)是一种慢性炎症性疾病,通常影响皮肤和粘膜。关于OLP是否与口腔念珠菌病有关,临床医生意见不一。尽管如此,在OLP患者中,口腔念珠菌病的患病率在7.7 - 16.6%之间,这是通过活检结果确定的,而在培养结果中发现的患病率为37-50%。口腔念珠菌病与几个局部和全身因素有关,包括唾液腺功能障碍、口腔修复、局部或吸入皮质类固醇、吸烟和全身药物的使用。目的是强调念珠菌在诊断为OLP的患者中的相关性,类固醇治疗的相关性,并列举使用类固醇治疗作为口腔念珠菌病的相关原因的因素。使用PubMed、Scopus、Cochrane系统评价数据库、Science Citation Index、NIH Public Access和Clarivate Analytics等搜索引擎进行搜索(图1)。使用该领域研究选项的关键词是“口腔念珠菌病”和“口腔平坦地衣”或“念珠菌病”和“皮质类固醇”或“外用皮质类固醇”和“口腔平坦地衣”或“吸入皮质类固醇”和“念珠菌病”或“口腔平坦地衣”和“皮质类固醇”。在1991年至2021年期间进行数据库检索(表1)。获得了关于OLP和口腔念珠菌病的文献的其他文章,并将其视为背景资料。口腔念珠菌病的发病率和相关的扁平苔藓后类固醇治疗征募由不同的作者已经解决。根据本研究的结果,在接受皮质类固醇治疗的OLP患者中,口腔念珠菌病存在正相关。最后,本荟萃分析得出结论,在OLP中念珠菌种类的存在与类固醇药物之间存在正相关。
{"title":"Association of oral candidiasis with oral lichen planus in patients using corticosteroid therapy - Meta-analysis.","authors":"Sulaiman S Alqahtani,&nbsp;Faris M Alabeedi","doi":"10.47750/jptcp.2023.1020","DOIUrl":"https://doi.org/10.47750/jptcp.2023.1020","url":null,"abstract":"<p><p>Oral lichen planus (OLP) is a chronic inflammatory disease that commonly affects the skin and mucous membranes. There is a difference of opinion among clinicians about whether OLP has been associated with oral candidiasis. Nonetheless, in OLP patients, the oral candidiasis prevalence rate ranges from 7.7 to 16.6%, as established through biopsy findings, whereas 37-50% of the prevalence rate has been noticed in culture findings. Oral candidiasis has been linked to several local and systemic factors, including salivary gland dysfunction, dental prostheses, topical or inhaled corticosteroids, smoking, and the use of systemic medications. The aim was to highlight the association of Candida in patients diagnosed with OLP, correlate the use of steroid therapy, and enumerate the factors of using steroid therapy as implicated causes for oral candidiasis. A search was made using search engines such as PubMed, Scopus, Cochrane Database of Systematic Reviews, Science Citation Index, NIH Public Access, and Clarivate Analytics (Figure 1). The keywords using the research option for this field were \"Oral Candidiasis\" AND \"Oral Lichen planus\" or \"Candidiasis\" AND \"Corticosteroids\" or \"Topical Corticosteroids\" AND Oral Lichen planus or \"Inhalation Corticosteroids\" AND \"Candidiasis\" or \"Oral Lichen planus\" AND \"Corticosteroids.\" The database search was made for the duration of 1991 to -2021 (Table 1). Additional articles were obtained regarding the literature on OLP and oral candidiasis and were considered background material. The incidence of oral candidiasis and associated lichen planus following steroid therapy enlisted by various authors has been addressed. According to the results of this study, there is a positive correlation between the presence of oral candidiasis in the OLP's patients treated with corticosteroids. Finally, this meta-analysis concluded that there is a positive correlation between the presence of Candida species in OLP and steroid medication.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"30 1","pages":"e1-e13"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9346441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of forward selection strategy using C4.5 algorithm to improve the accuracy of classification's data set. 应用C4.5算法的前向选择策略,提高分类数据集的准确率。
Etika Kartikadarma, Pandu Adi Cakranegara, Faisal Syafar, Akbar Iskandar, Arman Paramansyah, Robbi Rahim

The purpose of this study is to improve the classification accuracy of the C4.5 Algorithm utilizing the forward selection technique. Breast Cancer from the UCI Machine Learning Repository is the dataset utilized. There are 286 records in the dataset with nine attributes and one class (label). The suggested model was evaluated with two existing classification models (C4.5 and Naïve Bayes) using the RapidMiner program. The procedure consists of multiple stages, the first of which consists of selecting the dominant trait using the feature selection technique (weight by information gain). The second step is forward selection based on the outcome of feature selection. Before processing, the dataset is separated into training and testing halves, where the ratios of comparison are 70:30, 80:20, and 90:10. The final step is examining the output. The experimental results demonstrate that the forward selection methodology employing the C4.5 (C4.5 + FS) method outperforms the C4.5 and Naïve Bayes classification techniques. C4.5 + FS (Split Data 70:30) has an accuracy value of 76.74%, C4.5 + FS (Split Data 80:20) has an accuracy value of 78.95%, C4.5 + FS (Split Data 90:10) has an accuracy value of 78.57%, C4.5 (Split Data 70:30) has an accuracy value of 65.12%, and Naïve Bayes (Split Data is 70:30) has an accuracy value 85.55%. In comparison to typical classification algorithms (C4.5 and Naïve Bayes), the average accuracy values increased by 12.97% and 8.32%, respectively. In terms of precision, recall, and F-measure, the forward selection strategy utilizing the C4.5 method beat all other classification techniques, achieving 79.84%, 92.50%, and 85.55%, respectively. In addition, the results demonstrated an increase in the average Area Under Curve (AUC) from 0.628 to 0.732%. Therefore, it can be inferred that the forward selection strategy can be applied to the Breast Cancer Data Set in order to increase the accuracy value of classification method C4.5.

本研究的目的是利用正向选择技术提高C4.5算法的分类精度。UCI机器学习存储库中的乳腺癌是使用的数据集。数据集中有286条记录,有9个属性和1个类(标签)。使用RapidMiner程序使用两个现有的分类模型(C4.5和Naïve Bayes)对建议的模型进行评估。该过程包括多个阶段,第一步是使用特征选择技术(信息增益加权)选择优势性状。第二步是基于特征选择结果的正向选择。在处理之前,将数据集分为训练和测试两部分,其中比较比例为70:30、80:20和90:10。最后一步是检查输出。实验结果表明,采用C4.5 (C4.5 + FS)方法的前向选择方法优于C4.5和Naïve贝叶斯分类技术。C4.5 + FS (Split Data 70:30)的准确率值为76.74%,C4.5 + FS (Split Data 80:20)的准确率值为78.95%,C4.5 + FS (Split Data 90:10)的准确率值为78.57%,C4.5 (Split Data 70:30)的准确率值为65.12%,Naïve贝叶斯(Split Data 70:30)准确率值为85.55%。与典型分类算法(C4.5和Naïve Bayes)相比,平均准确率分别提高了12.97%和8.32%。在准确率、召回率和F-measure方面,使用C4.5方法的前向选择策略分别达到79.84%、92.50%和85.55%,优于所有其他分类技术。平均曲线下面积(AUC)由0.628增加到0.732%。因此,可以推断,可以将前向选择策略应用于乳腺癌数据集,以提高分类方法C4.5的准确率值。
{"title":"Application of forward selection strategy using C4.5 algorithm to improve the accuracy of classification's data set.","authors":"Etika Kartikadarma,&nbsp;Pandu Adi Cakranegara,&nbsp;Faisal Syafar,&nbsp;Akbar Iskandar,&nbsp;Arman Paramansyah,&nbsp;Robbi Rahim","doi":"10.47750/jptcp.2023.1002","DOIUrl":"https://doi.org/10.47750/jptcp.2023.1002","url":null,"abstract":"<p><p>The purpose of this study is to improve the classification accuracy of the C4.5 Algorithm utilizing the forward selection technique. Breast Cancer from the UCI Machine Learning Repository is the dataset utilized. There are 286 records in the dataset with nine attributes and one class (label). The suggested model was evaluated with two existing classification models (C4.5 and Naïve Bayes) using the RapidMiner program. The procedure consists of multiple stages, the first of which consists of selecting the dominant trait using the feature selection technique (weight by information gain). The second step is forward selection based on the outcome of feature selection. Before processing, the dataset is separated into training and testing halves, where the ratios of comparison are 70:30, 80:20, and 90:10. The final step is examining the output. The experimental results demonstrate that the forward selection methodology employing the C4.5 (C4.5 + FS) method outperforms the C4.5 and Naïve Bayes classification techniques. C4.5 + FS (Split Data 70:30) has an accuracy value of 76.74%, C4.5 + FS (Split Data 80:20) has an accuracy value of 78.95%, C4.5 + FS (Split Data 90:10) has an accuracy value of 78.57%, C4.5 (Split Data 70:30) has an accuracy value of 65.12%, and Naïve Bayes (Split Data is 70:30) has an accuracy value 85.55%. In comparison to typical classification algorithms (C4.5 and Naïve Bayes), the average accuracy values increased by 12.97% and 8.32%, respectively. In terms of precision, recall, and F-measure, the forward selection strategy utilizing the C4.5 method beat all other classification techniques, achieving 79.84%, 92.50%, and 85.55%, respectively. In addition, the results demonstrated an increase in the average Area Under Curve (AUC) from 0.628 to 0.732%. Therefore, it can be inferred that the forward selection strategy can be applied to the Breast Cancer Data Set in order to increase the accuracy value of classification method C4.5.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"30 1","pages":"e14-e23"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9345939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of sirolimus pharmacokinetic variability identified using a nonlinear mixed effects approach: a systematic review. 使用非线性混合效应方法确定西罗莫司药代动力学变异性的预测因素:一项系统综述。
Janthima Methaneethorn, Premsuda Art-Arsa, Ramanya Kosiyaporn, Nattawut Leelakanok

Several sirolimus (SRL) population pharmacokinetics (PopPK) were conducted to explain its pharmacokinetic variability, and the results varied across studies. Thus, we conducted a systematic review to summarize significant predictors influencing SRL pharmacokinetic variability. Moreover, discrepancies in model methodologies across studies were also reviewed and discussed. Four databases (PubMed, CINAHL Complete, Science Direct, and Scopus) were systematically searched. The PICO framework was used to identify eligible studies conducted in humans and employ a nonlinear-mixed effects strategy. Based on the inclusion and exclusion criteria, 20 studies were included. SRL pharmacokinetics were explained using 1- or 2-compartment models. Only one study assessed the model using an external approach, while the rest employed basic or advanced internal approaches. Significant covariates influencing SRL pharmacokinetics were bodyweight, age, CYP3A5 polymorphism, gender, BSA, height, cyclosporine dose or trough concentration, triglyceride, total cholesterol, hematocrit, albumin, aspartate aminotransferase, alanine aminotransferase, and total bilirubin. Of these, bodyweight, age, and CYP3A5 polymorphism were the three most identified significant predictors for SRL clearance. This review summarizes significant predictors to predict SRL clearance, which can subsequently be used to individualize SRL maintenance dose. However, the PopPK model selected for such prediction should be based on the resemblance of population characteristics between the target population and those used to conduct the model. Moreover, the predictability of the models in the target population should be assessed before implementation in clinical practice.

通过几种西罗莫司(SRL)群体药代动力学(PopPK)来解释其药代动力学变异性,结果在不同的研究中有所不同。因此,我们进行了一项系统综述,总结影响SRL药代动力学变异性的重要预测因素。此外,还回顾和讨论了不同研究中模型方法的差异。系统检索了PubMed、CINAHL Complete、Science Direct和Scopus四个数据库。PICO框架用于确定在人类中进行的合格研究,并采用非线性混合效应策略。根据纳入和排除标准,纳入了20项研究。用1室或2室模型解释SRL的药代动力学。只有一项研究使用外部方法评估模型,而其余研究使用基本或高级内部方法。影响SRL药代动力学的显著协变量为体重、年龄、CYP3A5多态性、性别、BSA、身高、环孢素剂量或谷浓度、甘油三酯、总胆固醇、红细胞压积、白蛋白、天冬氨酸转氨酶、丙氨酸转氨酶和总胆红素。其中,体重、年龄和CYP3A5多态性是SRL清除率的三个最确定的显著预测因子。这篇综述总结了预测SRL清除的重要预测因素,这些预测因素随后可用于个性化SRL维持剂量。然而,选择用于这种预测的PopPK模型应该基于目标人群与用于进行模型的人群之间的群体特征的相似性。此外,在临床实践中实施之前,应该评估模型在目标人群中的可预测性。
{"title":"Predictors of sirolimus pharmacokinetic variability identified using a nonlinear mixed effects approach: a systematic review.","authors":"Janthima Methaneethorn, Premsuda Art-Arsa, Ramanya Kosiyaporn, Nattawut Leelakanok","doi":"10.47750/jptcp.2022.940","DOIUrl":"10.47750/jptcp.2022.940","url":null,"abstract":"<p><p>Several sirolimus (SRL) population pharmacokinetics (PopPK) were conducted to explain its pharmacokinetic variability, and the results varied across studies. Thus, we conducted a systematic review to summarize significant predictors influencing SRL pharmacokinetic variability. Moreover, discrepancies in model methodologies across studies were also reviewed and discussed. Four databases (PubMed, CINAHL Complete, Science Direct, and Scopus) were systematically searched. The PICO framework was used to identify eligible studies conducted in humans and employ a nonlinear-mixed effects strategy. Based on the inclusion and exclusion criteria, 20 studies were included. SRL pharmacokinetics were explained using 1- or 2-compartment models. Only one study assessed the model using an external approach, while the rest employed basic or advanced internal approaches. Significant covariates influencing SRL pharmacokinetics were bodyweight, age, <i>CYP3A5</i> polymorphism, gender, BSA, height, cyclosporine dose or trough concentration, triglyceride, total cholesterol, hematocrit, albumin, aspartate aminotransferase, alanine aminotransferase, and total bilirubin. Of these, bodyweight, age, and <i>CYP3A5</i> polymorphism were the three most identified significant predictors for SRL clearance. This review summarizes significant predictors to predict SRL clearance, which can subsequently be used to individualize SRL maintenance dose. However, the PopPK model selected for such prediction should be based on the resemblance of population characteristics between the target population and those used to conduct the model. Moreover, the predictability of the models in the target population should be assessed before implementation in clinical practice.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 4","pages":"e11-e29"},"PeriodicalIF":0.0,"publicationDate":"2022-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10761157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long COVID-19 prevalence among a sample of infected people in Erbil city. 埃尔比勒市感染者样本中COVID-19的长期流行率
Ahmed Sabah Hawar, Ali Shakir Dauod

Background: Long-term effects of the disease were founded and described as post-COVID-19 syndrome post-COVID syndrome are the symptoms that develop and last for four weeks or even months and cannot be explained by an alternative diagnosis; symptoms may remain for >3 months. The cause of persistent symptoms is unclear. Objectives: This study aimed to Estimate the prevalence of residual symptoms among a sample of people infected with COVID-19 who survived and recovered in Erbil city and to find out the relation between the severity of the disease and post-COVID-19 syndrome. And to know the incidence of post-COVID-19 syndrome in chronic disease patients.

Patients and methods: This cross-sectional study was conducted in 6 primary health care centers in 6 municipalities in Erbil city, Kurdistan region, Iraq. A convenience sample of randomly selected 300 patients was involved in the study depending on inclusion criteria. For one year, starting from March 1, 2021, until the end of February 2022.

Results: The prevalence of post-COVID syndrome among the 300 cases was 54.67%. Of these cases, 11.7% had one symptom, 26% had two signs, and 17% had with three or more symptoms. There was a significant statistical association between persistent symptoms and the severity of COVID-19. Also, there was a substantial statistical association between persistent symptoms and chronic disease, most (67.9%) respondents with post-COVID-19 syndromes suffered from chronic disease, and the p-value was 0.001. There was a significant statistical association between persistent symptoms and disease duration; most (73%) of cases with post-COVID-19 syndrome got the disease from 7 to 14 days, while 54.5% of them struggled with COVID-19 for >14 days.

Conclusion: Most people who have recovered from COVID-19 have many long-lasting symptoms that make it hard to go about their daily lives. This is now called a post-COVID syndrome. Getting to this status could have been caused by several things. Age, gender, whether a person has a chronic disease, disease severity, and duration are all things to consider, Even though all COVID-19 victims should be kept an eye on for long-term evaluation and treatment of post-COVID symptoms.

背景:该疾病的长期影响被发现并描述为covid -19后综合征- covid -19后综合征是指出现并持续四周甚至数月的症状,无法用其他诊断来解释;症状可能持续3个月以上。持续症状的原因尚不清楚。目的:本研究旨在估计埃尔比勒市幸存和康复的COVID-19感染者样本中残留症状的患病率,并找出疾病严重程度与COVID-19后综合征的关系。了解慢性疾病患者新冠肺炎后综合征的发生率。患者和方法:本横断面研究在伊拉克库尔德斯坦地区埃尔比勒市6个市的6个初级卫生保健中心进行。根据纳入标准,随机选择300名患者作为方便样本参与研究。为期一年,从2021年3月1日起至2022年2月底。结果:300例病例中新冠肺炎后综合征患病率为54.67%。在这些病例中,11.7%有一种症状,26%有两种症状,17%有三种或更多症状。持续症状与COVID-19严重程度之间存在显著的统计学关联。此外,持续症状与慢性疾病之间存在实质性的统计学关联,大多数(67.9%)患有covid -19后综合征的受访者患有慢性疾病,p值为0.001。持续症状与病程之间存在显著的统计学关联;大多数(73%)新冠肺炎后综合征患者发病时间为7 - 14天,54.5%的患者发病时间>14天。结论:大多数从COVID-19中康复的人都有许多长期症状,使他们难以进行日常生活。这现在被称为后covid综合征。达到这种状态可能是由几个因素造成的。年龄、性别、一个人是否患有慢性疾病、疾病严重程度和持续时间都是需要考虑的因素,尽管所有COVID-19受害者都应该关注COVID-19后症状的长期评估和治疗。
{"title":"Long COVID-19 prevalence among a sample of infected people in Erbil city.","authors":"Ahmed Sabah Hawar,&nbsp;Ali Shakir Dauod","doi":"10.47750/jptcp.2022.956","DOIUrl":"https://doi.org/10.47750/jptcp.2022.956","url":null,"abstract":"<p><strong>Background: </strong>Long-term effects of the disease were founded and described as post-COVID-19 syndrome post-COVID syndrome are the symptoms that develop and last for four weeks or even months and cannot be explained by an alternative diagnosis; symptoms may remain for >3 months. The cause of persistent symptoms is unclear. Objectives: This study aimed to Estimate the prevalence of residual symptoms among a sample of people infected with COVID-19 who survived and recovered in Erbil city and to find out the relation between the severity of the disease and post-COVID-19 syndrome. And to know the incidence of post-COVID-19 syndrome in chronic disease patients.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted in 6 primary health care centers in 6 municipalities in Erbil city, Kurdistan region, Iraq. A convenience sample of randomly selected 300 patients was involved in the study depending on inclusion criteria. For one year, starting from March 1, 2021, until the end of February 2022.</p><p><strong>Results: </strong>The prevalence of post-COVID syndrome among the 300 cases was 54.67%. Of these cases, 11.7% had one symptom, 26% had two signs, and 17% had with three or more symptoms. There was a significant statistical association between persistent symptoms and the severity of COVID-19. Also, there was a substantial statistical association between persistent symptoms and chronic disease, most (67.9%) respondents with post-COVID-19 syndromes suffered from chronic disease, and the p-value was 0.001. There was a significant statistical association between persistent symptoms and disease duration; most (73%) of cases with post-COVID-19 syndrome got the disease from 7 to 14 days, while 54.5% of them struggled with COVID-19 for >14 days.</p><p><strong>Conclusion: </strong>Most people who have recovered from COVID-19 have many long-lasting symptoms that make it hard to go about their daily lives. This is now called a post-COVID syndrome. Getting to this status could have been caused by several things. Age, gender, whether a person has a chronic disease, disease severity, and duration are all things to consider, Even though all COVID-19 victims should be kept an eye on for long-term evaluation and treatment of post-COVID symptoms.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e123-e133"},"PeriodicalIF":0.0,"publicationDate":"2022-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Human development index and innovation capabilities in the health sector of UAE. 阿联酋卫生部门的人类发展指数和创新能力。
Sultan Mohamed Al-Marzooqi, Ashraf M Zedan Al Dulaimi, Asmuliadi Lubis, Norrodzoh Binti Hj Siren, Sayyid Buhar Kassim

Based on human capital theory, the goal of this study was to look into the role of innovation capabilities in the UAE healthcare sector's competitiveness. Following the qualitative research design, data were gathered through interviews with 90 experts and professionals working in the health industry in UAE. Furthermore, the study also analyzed the UAE's Human Development Index (HDI), innovation capacities, and human development competitiveness from 2014 to 2020 using the conceptual statistics of Key Performance Indicators (KPIs) obtained in the health sector. Results revealed that UAE achieved some positive indicator results from 2020 to 2021. In addition, there are significant areas of improvement through which the UAE can build a better rank in the global competitiveness index of the health sector. The study provided key policy insights for understanding the strengths and weaknesses of innovation capabilities and human development competitiveness in the healthcare sector. Avenues of growth policy and future research directions are suggested.

基于人力资本理论,本研究的目的是探讨创新能力在阿联酋医疗保健部门竞争力中的作用。根据定性研究设计,通过对90名在阿联酋卫生行业工作的专家和专业人员的访谈收集数据。此外,该研究还利用在卫生部门获得的关键绩效指标(kpi)的概念统计数据,分析了2014年至2020年阿联酋的人类发展指数(HDI)、创新能力和人类发展竞争力。结果显示,阿联酋在2020年至2021年期间取得了一些积极的指标成果。此外,还有一些重大的改进领域,通过这些领域,阿联酋可以在卫生部门的全球竞争力指数中获得更好的排名。该研究为了解医疗保健行业创新能力和人类发展竞争力的优势和劣势提供了关键的政策见解。提出了增长政策的途径和未来的研究方向。
{"title":"Human development index and innovation capabilities in the health sector of UAE.","authors":"Sultan Mohamed Al-Marzooqi,&nbsp;Ashraf M Zedan Al Dulaimi,&nbsp;Asmuliadi Lubis,&nbsp;Norrodzoh Binti Hj Siren,&nbsp;Sayyid Buhar Kassim","doi":"10.47750/jptcp.2022.959","DOIUrl":"https://doi.org/10.47750/jptcp.2022.959","url":null,"abstract":"<p><p>Based on human capital theory, the goal of this study was to look into the role of innovation capabilities in the UAE healthcare sector's competitiveness. Following the qualitative research design, data were gathered through interviews with 90 experts and professionals working in the health industry in UAE. Furthermore, the study also analyzed the UAE's Human Development Index (HDI), innovation capacities, and human development competitiveness from 2014 to 2020 using the conceptual statistics of Key Performance Indicators (KPIs) obtained in the health sector. Results revealed that UAE achieved some positive indicator results from 2020 to 2021. In addition, there are significant areas of improvement through which the UAE can build a better rank in the global competitiveness index of the health sector. The study provided key policy insights for understanding the strengths and weaknesses of innovation capabilities and human development competitiveness in the healthcare sector. Avenues of growth policy and future research directions are suggested.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e134-e156"},"PeriodicalIF":0.0,"publicationDate":"2022-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of the proposed DCNN model with standard CNN architectures for retinal diseases classification. 提出的DCNN模型与标准CNN体系结构用于视网膜疾病分类的比较。
Ramya Mohan, Kirupa Ganapathy, Rama Arunmozhi

Deep learning in medical image analysis has indicated increasing interest in the classification of signs of abnormalities. In this study, a new convolutional neural network (CNN) architecture (MIDNet18) Medical Image Detection Network was proposed for the classification of retinal diseases using optical coherence tomography (OCT) images. The model consists of 14 convolutional layers, seven Max Pooling layers, four dense layers, and one classification layer. A multi-class classification layer in the MIDNet18 is used to classify the OCT images into either normal or any of the three abnormal types: Choroidal Neovascularization (CNV), Drusen, and Diabetic Macular Edema (DME). The dataset consists of 83,484 training images, 41,741 validation images, and 968 test images. According to the experimental results, MIDNet18 obtains an accuracy of 98.86%, and their performances are compared with other standard CNN models; ResNet-50 (83.26%), MobileNet (93.29%) and DenseNet (92.5%). Also, MIDNet18 with a p-value < 0.001 has been proved to be statistically significant than other standard CNN architectures in classifying retinal diseases using OCT images.

医学图像分析中的深度学习表明,对异常迹象的分类越来越感兴趣。本研究提出了一种新的卷积神经网络(CNN)架构(MIDNet18)医学图像检测网络,用于光学相干断层扫描(OCT)图像的视网膜疾病分类。该模型由14个卷积层、7个最大池化层、4个密集层和1个分类层组成。MIDNet18中的多类分类层用于将OCT图像分为正常或三种异常类型中的任何一种:脉络膜新生血管(CNV), Drusen和糖尿病性黄斑水肿(DME)。该数据集由83484张训练图像、41741张验证图像和968张测试图像组成。根据实验结果,MIDNet18获得了98.86%的准确率,并与其他标准CNN模型进行了性能比较;ResNet-50(83.26%)、MobileNet(93.29%)和DenseNet(92.5%)。此外,在使用OCT图像对视网膜疾病进行分类时,已证明p值< 0.001的MIDNet18比其他标准CNN架构具有统计学意义。
{"title":"Comparison of the proposed DCNN model with standard CNN architectures for retinal diseases classification.","authors":"Ramya Mohan,&nbsp;Kirupa Ganapathy,&nbsp;Rama Arunmozhi","doi":"10.47750/jptcp.2022.945","DOIUrl":"https://doi.org/10.47750/jptcp.2022.945","url":null,"abstract":"<p><p>Deep learning in medical image analysis has indicated increasing interest in the classification of signs of abnormalities. In this study, a new convolutional neural network (CNN) architecture (MIDNet18) Medical Image Detection Network was proposed for the classification of retinal diseases using optical coherence tomography (OCT) images. The model consists of 14 convolutional layers, seven Max Pooling layers, four dense layers, and one classification layer. A multi-class classification layer in the MIDNet18 is used to classify the OCT images into either normal or any of the three abnormal types: Choroidal Neovascularization (CNV), Drusen, and Diabetic Macular Edema (DME). The dataset consists of 83,484 training images, 41,741 validation images, and 968 test images. According to the experimental results, MIDNet18 obtains an accuracy of 98.86%, and their performances are compared with other standard CNN models; ResNet-50 (83.26%), MobileNet (93.29%) and DenseNet (92.5%). Also, MIDNet18 with a <i>p</i>-value < 0.001 has been proved to be statistically significant than other standard CNN architectures in classifying retinal diseases using OCT images.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e112-e122"},"PeriodicalIF":0.0,"publicationDate":"2022-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation of new surgical technique to contour the missing bone in the face of survivors of traffic and war injuries by new modified Problast painted with a mixture of biocompatible materials. 创新新的外科技术,通过新的改良Problast涂上生物相容性材料的混合物,为交通和战争受伤的幸存者提供轮廓缺失的骨骼。
Sabah Hassan

The bone grafts taken from the patient himself (Auto genius graft) to restore the contour of the lost facial bone lost is the ideal technique on the road to recovery from injuries of war or traffic accidents. This novel surgical procedure utilizes a new modified Problast painted with a mixture of a biocompatible materials to restore the lost parts of the zygomatic bones, due to traffic accidents, shell injuries, or bullet injuries.

自体骨移植(Auto genius graft)是修复战争或交通事故损伤的理想方法。这种新颖的外科手术采用了一种新型改良的Problast,涂上一种生物相容性材料的混合物,用于修复因交通事故、炮弹伤或子弹伤而丢失的颧骨部分。
{"title":"Innovation of new surgical technique to contour the missing bone in the face of survivors of traffic and war injuries by new modified Problast painted with a mixture of biocompatible materials.","authors":"Sabah Hassan","doi":"10.47750/jptcp.2022.949","DOIUrl":"https://doi.org/10.47750/jptcp.2022.949","url":null,"abstract":"<p><p>The bone grafts taken from the patient himself (Auto genius graft) to restore the contour of the lost facial bone lost is the ideal technique on the road to recovery from injuries of war or traffic accidents. This novel surgical procedure utilizes a new modified Problast painted with a mixture of a biocompatible materials to restore the lost parts of the zygomatic bones, due to traffic accidents, shell injuries, or bullet injuries.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e109-e111"},"PeriodicalIF":0.0,"publicationDate":"2022-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33488639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Accuracy of office hysteroscopy in diagnosis of endometrial pathologies compared to ultrasound and histopathology in Baghdad Teaching Hospital. 巴格达教学医院宫腔镜与超声及组织病理学诊断子宫内膜病变的准确性比较。
Farah Abdul Hussein Salih Al-Asadi, Shaymaa Kadhim Jasim

Background: Menstrual problems with all manifestations ranging from life-threatening bleeding to amenorrhea are considered patterns of abnormal uterine bleeding (AUB), which is until now a popular reason for referral to the gynaecologic clinic and requires a special diagnostic tool.

Objective: To assess the accuracy of hysteroscopy in diagnosing endometrial pathologies and to compare it with sonographic and histopathologic reports.

Patients and methods: A prospective study conducted in the Baghdad Teaching Hospital on 60 Iraqi females having varying complaints from abnormal uterine bleeding in pre- and post-menopausal women, infertility, and chronic pelvic pain with normal or abnormal ultrasound findings. Office hysteroscopy was done and an endometrial biopsy was obtained for histopathology for a period of 10 months between September 2020 and June 2021.

Results: The current study showed that hysteroscopy was more accurate in diagnosing sensitivity of endometrial poly (100%), fibroids (83%), hyperplasia (84.2%), and cancer (50%) whereas ultrasounds were more accurate in diagnosing sensitivity to endometrial myoma (90%). Hysteroscopy and ultrasound showed low sensitivity in detecting endometrial cancer (50% and 34%, respectively).

Conclusion: Although a transvaginal ultrasound was considered an integral part in the diagnosis of endometrial pathologies, it can be used for initial investigation, however, when suspecting endometrial pathology, hysteroscopy can be more advanced for evaluation, immediate treatment of endometrial masses, and obtaining targeted biopsies. Hysteroscopy showed high sensitivity in detecting endometrial polyps.

背景:月经问题的所有表现,从危及生命的出血到闭经,都被认为是子宫异常出血(AUB)的模式,直到现在,这是一个普遍的原因,转介到妇科诊所,需要一个特殊的诊断工具。目的:评价宫腔镜诊断子宫内膜病变的准确性,并与超声和组织病理学报告进行比较。患者和方法:在巴格达教学医院对60名伊拉克女性进行了一项前瞻性研究,这些女性有不同的主诉,包括绝经前和绝经后妇女子宫异常出血、不孕症和慢性盆腔疼痛,超声检查结果正常或异常。在2020年9月至2021年6月的10个月期间,进行了办公室宫腔镜检查并进行了子宫内膜活检以进行组织病理学检查。结果:宫腔镜对子宫内膜息肉(100%)、肌瘤(83%)、增生(84.2%)、癌(50%)的诊断敏感性更高,超声对子宫内膜肌瘤(90%)的诊断敏感性更高。宫腔镜和超声对子宫内膜癌的检测灵敏度较低(分别为50%和34%)。结论:虽然经阴道超声被认为是子宫内膜病理诊断的重要组成部分,但可用于初步调查,但当怀疑子宫内膜病理时,宫腔镜可更先进地进行评估,立即治疗子宫内膜肿块,并进行有针对性的活检。宫腔镜检查子宫内膜息肉具有较高的敏感性。
{"title":"Accuracy of office hysteroscopy in diagnosis of endometrial pathologies compared to ultrasound and histopathology in Baghdad Teaching Hospital.","authors":"Farah Abdul Hussein Salih Al-Asadi,&nbsp;Shaymaa Kadhim Jasim","doi":"10.47750/jptcp.2022.954","DOIUrl":"https://doi.org/10.47750/jptcp.2022.954","url":null,"abstract":"<p><strong>Background: </strong>Menstrual problems with all manifestations ranging from life-threatening bleeding to amenorrhea are considered patterns of abnormal uterine bleeding (AUB), which is until now a popular reason for referral to the gynaecologic clinic and requires a special diagnostic tool.</p><p><strong>Objective: </strong>To assess the accuracy of hysteroscopy in diagnosing endometrial pathologies and to compare it with sonographic and histopathologic reports.</p><p><strong>Patients and methods: </strong>A prospective study conducted in the Baghdad Teaching Hospital on 60 Iraqi females having varying complaints from abnormal uterine bleeding in pre- and post-menopausal women, infertility, and chronic pelvic pain with normal or abnormal ultrasound findings. Office hysteroscopy was done and an endometrial biopsy was obtained for histopathology for a period of 10 months between September 2020 and June 2021.</p><p><strong>Results: </strong>The current study showed that hysteroscopy was more accurate in diagnosing sensitivity of endometrial poly (100%), fibroids (83%), hyperplasia (84.2%), and cancer (50%) whereas ultrasounds were more accurate in diagnosing sensitivity to endometrial myoma (90%). Hysteroscopy and ultrasound showed low sensitivity in detecting endometrial cancer (50% and 34%, respectively).</p><p><strong>Conclusion: </strong>Although a transvaginal ultrasound was considered an integral part in the diagnosis of endometrial pathologies, it can be used for initial investigation, however, when suspecting endometrial pathology, hysteroscopy can be more advanced for evaluation, immediate treatment of endometrial masses, and obtaining targeted biopsies. Hysteroscopy showed high sensitivity in detecting endometrial polyps.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e104-e108"},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33488638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Formulation, development, and evaluation of anti-inflammatory and antimicrobial effects of a novel polyherbal mouthwash-An in vitro study. 新型多草本漱口水的配制、开发和抗炎抗菌效果评估--一项体外研究。
Bhavana Garapati, Jaiganesh Ramamurthy, Rajeshkumar Shanmugam

Aim: The aim of this study was to prepare a polyherbal mouthwash and evaluate its antimicrobial and anti-inflammatory efficacy against commercially available herbal mouthwash. The objective was to signify whether the novel herbal combination (extracts of Zingiber officinale [ginger], Curcuma longa [turmeric], and Syzygium aromaticum [clove] 5% v/w) could be a better alternative to commercially available herbal mouthwashes.

Materials and methods: An in vitro study was undertaken in which extracts of Z. officinale (ginger), C. longa (turmeric), and S. aromaticum (clove) 5% v/w were used. Seven different concentrations were prepared and tested against Streptococcus mutans, Enterococcus faecalis, Candida albicans, and Staphylococcus aureus in Mueller-Hinton agar medium. Plates were incubated aerobically at 37° C for 48 h, and the zone of inhibition was measured using a vernier caliper. Commercially available herbal mouthwash (Hiora) was used as a control group. The data were analyzed by descriptive analytics.

Results: Results showed that the efficacy of novel polyherbal mouthwash had comparatively less significant antimicrobial properties against the microorganisms as compared to the commercially available herbal mouthwash. The minimum inhibitory concentration was also found to be very high, that is, 100 μg/mL.

Conclusion: There was no significant antimicrobial and anti-inflammatory effects for the polyherbal mouthwash as compared to commercially available herbal mouthwash (Hiora). Because this combination is readily available, it can be a cost-effective alternative to commercially available herbal mouthwashes.

目的:本研究旨在制备一种多草药漱口水,并评估其与市售草药漱口水的抗菌和消炎功效。目的是确定新型草药组合(生姜、姜黄和丁香 5% v/w 的提取物)是否能更好地替代市售草药漱口水:进行了一项体外研究,使用了 5%(体积分数)的生姜、姜黄和丁香提取物。制备了七种不同浓度的提取物,并在穆勒-欣顿琼脂培养基中对变异链球菌、粪肠球菌、白色念珠菌和金黄色葡萄球菌进行了测试。培养皿在 37° C 下有氧培养 48 小时,然后用游标卡尺测量抑菌区。市售草本漱口水(Hiora)作为对照组。数据采用描述性分析法进行分析:结果表明,与市售草本漱口水相比,新型多草本漱口水对微生物的抗菌效果相对较弱。最低抑菌浓度也很高,为 100 μg/mL:结论:与市售草药漱口水(Hiora)相比,复方草药漱口水没有明显的抗菌和消炎效果。由于这种复方草药漱口水很容易买到,因此可以作为市售草药漱口水的一种具有成本效益的替代品。
{"title":"Formulation, development, and evaluation of anti-inflammatory and antimicrobial effects of a novel polyherbal mouthwash-An <i>in vitro</i> study.","authors":"Bhavana Garapati, Jaiganesh Ramamurthy, Rajeshkumar Shanmugam","doi":"10.47750/jptcp.2022.943","DOIUrl":"10.47750/jptcp.2022.943","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to prepare a polyherbal mouthwash and evaluate its antimicrobial and anti-inflammatory efficacy against commercially available herbal mouthwash. The objective was to signify whether the novel herbal combination (extracts of <i>Zingiber officinale</i> [ginger], <i>Curcuma longa</i> [turmeric], and <i>Syzygium aromaticum</i> [clove] 5% v/w) could be a better alternative to commercially available herbal mouthwashes.</p><p><strong>Materials and methods: </strong>An in vitro study was undertaken in which extracts of <i>Z. officinale</i> (ginger), <i>C. longa</i> (turmeric), <i>and S. aromaticum</i> (clove) 5% v/w were used. Seven different concentrations were prepared and tested against <i>Streptococcus mutans, Enterococcus faecalis, Candida albicans</i>, and <i>Staphylococcus aureus</i> in Mueller-Hinton agar medium. Plates were incubated aerobically at 37° C for 48 h, and the zone of inhibition was measured using a vernier caliper. Commercially available herbal mouthwash (Hiora) was used as a control group. The data were analyzed by descriptive analytics.</p><p><strong>Results: </strong>Results showed that the efficacy of novel polyherbal mouthwash had comparatively less significant antimicrobial properties against the microorganisms as compared to the commercially available herbal mouthwash. The minimum inhibitory concentration was also found to be very high, that is, 100 μg/mL.</p><p><strong>Conclusion: </strong>There was no significant antimicrobial and anti-inflammatory effects for the polyherbal mouthwash as compared to commercially available herbal mouthwash (Hiora). Because this combination is readily available, it can be a cost-effective alternative to commercially available herbal mouthwashes.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 3","pages":"e94-e103"},"PeriodicalIF":0.0,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33488637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1